salzburg.ORF.at – Date: 01.06.2024
Author: red, salzburg.ORF.at – Source
Novogenia, a biotech company specializing in genetic analysis, plans to build a new headquarters in Hallwang, Austria, with an investment of around 30 million euros. The new facility will replace the current headquarters in Eugendorf, which has become too small due to the company’s growth. The new site will triple the production space to 11,000 square meters and accommodate up to 350 employees, compared to the current 100. The new headquarters will also feature advanced robotics to support production. Construction is set to begin this year, pending final approvals, with a target annual revenue of 500 million euros at the new location.
